Press Releases

Dignitana AB Announces Change of Publication Date for Third Quarter 2018 Interim Report

Dignitana AB announced today that the Third Quarter 2018 Interim Report will be published the 16th of November instead of the previously posted date of 27 November 2018.

Financial Calendar
16 November 2018   -- Q3 Interim Report through 30 September 2018
26 February 2019   -- 2018 Year End Report  
Past Annual Reports and Interim Reports are available at

FRI, OCT 19, 2018

Company Contact
William Cronin, CEO, Dignitana AB +1 469 917 5555
Mikael Wahlgren, Vice VD, Dignitana AB   +46 709 33 72 20

About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser.  Learn more at and


Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90